View in EDS HTML Full Text PDF Full Text

ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer.
Authors: Fan Z; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Luo G; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Gong Y; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China., Liu C; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org., Yu X; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.
Source: Annals of surgical oncology [Ann Surg Oncol] 2020 Oct; Vol. 27 (10), pp. 4026-4027. Date of Electronic Publication: 2020 Apr 08.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32270422
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fan+Z%22">Fan Z</searchLink>; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Luo+G%22">Luo G</searchLink>; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Gong+Y%22">Gong Y</searchLink>; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. liuchen@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. liuchen@fudanpci.org.<br /><searchLink fieldCode="AU" term="%22Yu+X%22">Yu X</searchLink>; Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Shanghai Pancreatic Cancer Institute, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.; Pancreatic Cancer Institute, Fudan University, Shanghai, People's Republic of China. yuxianjun@fudanpci.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229420840%22">Annals of surgical oncology</searchLink> [Ann Surg Oncol] 2020 Oct; Vol. 27 (10), pp. 4026-4027. <i>Date of Electronic Publication: </i>2020 Apr 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9420840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1534-4681 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210689265%22">10689265 </searchLink><i>NLM ISO Abbreviation: </i>Ann Surg Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32270422
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1245/s10434-020-08335-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4026
    Titles:
      – TitleFull: ASO Author Reflections: C-Reactive Protein/Lymphocyte Ratio as a Promising Marker for Predicting Survival in Pancreatic Cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fan Z
      – PersonEntity:
          Name:
            NameFull: Luo G
      – PersonEntity:
          Name:
            NameFull: Gong Y
      – PersonEntity:
          Name:
            NameFull: Liu C
      – PersonEntity:
          Name:
            NameFull: Yu X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2020 Oct
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1534-4681
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Annals of surgical oncology
              Type: main
ResultId 1